Mutations in the first three identified genes—KCNQ1 for LQT1, KCNH2 for LQT2 and SCN5A for LQT3—account for approximately 90% of genetically affected LQTS patients, while those in other causal genes have rarely been identified [1]. This evidence concerns the gene SCN5A and familial long QT syndrome.